Kathy D Miller, MD
@kathydmillermd.bsky.social
๐ค 260
๐ฅ 243
๐ 30
Medical Oncologist, breast cancer researcher, nature lover, mother of two teenagers
reposted by
Kathy D Miller, MD
American Cancer Society
5 days ago
๐ Congratulations to Dr. Nancy Davidson from
@fredhutch.org
on receiving ๐๐ต๐ฒ ๐๐ฎ๐๐ถ๐ฑ ๐๐ฎ๐ฟ๐ป๐ผ๐ณ๐๐ธ๐ ๐ฆ๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ ๐ผ๐ณ ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ ๐๐๐ฎ๐ฟ๐ฑ from the American Society of Clinical Oncology (ASCO) and presenting her award lecture during this morning's Opening Session at
#ASCO26
.
1
6
2
reposted by
Kathy D Miller, MD
JCO Journals
8 days ago
High-impact research is a benchmark of success. Join JCO Journal editors for "The Ins and Outs of Medical Publishing" at
#ASCO26
: Friday, May 29 1 โ 3:15 PM (CT) Room S103 Elevate your authorship skills and advance oncology. View the full schedule:
https://bit.ly/4nGnIRf
0
1
2
Join JCO editors at ASCO26. We have one on one mentoring sessions available in the JCO central lounge
16 days ago
0
2
0
Still seats on the Pacerโs bandwagon if youโd like to jump on๐โน๐ปโโ๏ธ
12 months ago
0
2
0
reposted by
Kathy D Miller, MD
MidwestHedonist
about 1 year ago
Spread the love and acceptance
#pridemonth
361
19935
15520
Great time with early career attendees today at the JCO poster walk this morning The future of our field is indeed bright
about 1 year ago
0
3
0
Serena 6 AI PFS 9.2 mos + 6.3 mos (PFS 2nd line cami)= 15.5 Sounds like the 16 mos with early switch? I knowโฆ. Cross trial comparisons are hard but lead time bias is real
about 1 year ago
0
2
0
Have to ask how Serena 6 got into NEJM? PFS2 as defined is really PFS2 in control arm vs PFS3 in cami arm Uninterpretable and real potential that pts will move to chemo sooner than needed
about 1 year ago
0
2
0
My new favorite assessment The SMOG readability score SMOG = simple measure of gobbledygook Use it to determine the education level needed for comprehension
about 1 year ago
0
1
0
Shout out to Gilead and the Ascent 4 trial for providing an opportunity to crossover to pts randomized toTPC. Finally respect for pts who agree to participate
about 1 year ago
0
0
0
Stop by JCO central while at ASCO. Enjoy the coffee, meet the editors and staff, learn more about JCO
about 1 year ago
0
2
1
No questions allowed after the EMBER 3 presentation How is endocrine therapy alone SOC for the 40 percent with no prior CDKi exposure? When they amended to add illum plus abema arm they should have added SOC plus abema too Without that control, the data are impossible to interpret
over 1 year ago
0
4
0
Itโs almost SABCS time. If your attending stop by poster session 1 to learn about epigenetic therapy plus PARPisโฆ just to say hello
over 1 year ago
0
5
0
For the real testes cancer/Einhorn fans, the full event can be viewed here....you are responsible for your own tissues!
www.youtube.com/watch?v=klOA...
loading . . .
Larry Einhorn: Celebrating 50 years of the cure
YouTube video by IU Simon Comprehensive Cancer Center
https://www.youtube.com/watch?v=klOASlFDYRA
over 1 year ago
0
5
0
reposted by
Kathy D Miller, MD
It was an honor to celebrate Dr. Larry Einhorn and the 50th anniversary of the cure for testis cancer. Former patients, colleagues, trainees, and family all joined a special evening. You can catch a glimpse of the fun - if you know Larry, please send him a note
www.youtube.com/watch?v=U2Iu...
loading . . .
Larry Einhorn: Celebrating 50 years of the cure
YouTube video by IU Simon Comprehensive Cancer Center
https://www.youtube.com/watch?v=U2Iu_VA3q_E
over 1 year ago
0
4
1
It was an honor to celebrate Dr. Larry Einhorn and the 50th anniversary of the cure for testis cancer. Former patients, colleagues, trainees, and family all joined a special evening. You can catch a glimpse of the fun - if you know Larry, please send him a note
www.youtube.com/watch?v=U2Iu...
loading . . .
Larry Einhorn: Celebrating 50 years of the cure
YouTube video by IU Simon Comprehensive Cancer Center
https://www.youtube.com/watch?v=U2Iu_VA3q_E
over 1 year ago
0
4
1
Don't miss this rapid update to the ASCO Small Cell Lng Cancer guidelines
sites.libsyn.com/115284/syste...
Recently published results of the phase III ADRIATIC trial (consolidation durva) and the phase II DeLLphi-301 (tarlatamab) prompted this important update
loading . . .
ASCO Guidelines: Systemic Therapy for SCLC Rapid Update
Dr. Greg Kalemkerian reviews the latest evidence-based rapid update from the Expert Panel on systemic therapy for small cell lung cancer. He discusses the updated recommendations for patients with lim...
http://sites.libsyn.com/115284/systemic-therapy-for-sclc-rapid-update
over 1 year ago
0
3
0
you reached the end!!
feeds!
log in